Financials
- Market Capitalization 70.96 M
- Employee 33
- Founded 2011
- CEO N/A
- Website www.elicio.com
- Headquarter Delaware, United States
- FIGI BBG00444GM02
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.84
Relación precio/flujo de caja
5 105.86
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4099 | ANVS Annovis Bio, Inc. Common Stock | 1.74 USD | +1.16% | -1.14% | -1.69% | -24.68% | 74.13 M USD | ||
| 4111 | SPRO Spero Therapeutics, Inc. - Common Stock | 1.22 USD | +1.67% | -0.81% | +3.39% | -40.20% | 71.05 M USD | ||
| 4116 | MNOV MediciNova, Inc. - Common Stock | 1.44 USD | 0.00% | -7.10% | +9.09% | +10.77% | 70.88 M USD | ||
| 4121 | XBIT XBiotech Inc. - Common Stock | 2.30 USD | +1.32% | 0.00% | +3.60% | -26.98% | 70.12 M USD |